Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. A platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnoses and treatment plans. Treatment plans for the treatment and management of the disease require individual development, typically including pharmacotherapy, rehabilitation interventions, regular follow-up, etc.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule of disease changes. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of family screening for primary carcinogen deficiency.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.